RECBIO-B (02179) completes the directed issuance of domestic shares.
Ruike Biotechnology-B (02179) announced that the company received the share registration certificate issued by China Securities Depository and Clearing Co., Ltd. on December 15, 2025, on December 17, 2025. According to this, 143 million domestic shares have been credited as fully paid for and issued to the subscribers. This issuance has been completed.
RECBIO-B(02179) Announcement: The company received a stock registration certificate from the China Securities Depository and Clearing Corporation Limited on December 17, 2025, with a date of December 15, 2025 for this issuance. Accordingly, 143 million domestic shares have been accounted for as fully paid and issued to subscribers, and this issuance has been completed.
Therefore, following the completion of this issuance, the total number of shares issued by the company is 626 million, including 298 million domestic shares, 12 million unlisted foreign shares, and 316 million H shares.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


